Staphylococcus aureus induces IL-1β expression through the activation of MAP kinases and AP-1, CRE and NF-κB transcription factors in the bovine mammary gland epithelial cells

Comparative Immunology, Microbiology and Infectious Diseases

Volumn 34, Issue 4, 2011, Pages 347-354

  Kim, Kyoung Whun ^a   Im, Jintaek ^a   Jeon, Jun Ho ^a   Lee, Hong Gu ^b   Yun, Cheol Heui ^a   Han, Seung Hyun ^a  

^a Seoul National University   (South Korea)

^b Pusan National University   (South Korea)

Author keywords

Bovine mammary gland epithelial cells; IL 1 ; Innate immunity; Mastitis; Staphylococcus aureus

Indexed keywords

IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 1BETA; LIPOTEICHOIC ACID; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE P38; PEPTIDOGLYCAN; STRESS ACTIVATED PROTEIN KINASE; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR AP 1; TRANSCRIPTION FACTOR CRE; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; BACTERIAL CELL WALL; BREAST EPITHELIUM; CELL STIMULATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; ENZYME ACTIVATION; GENE EXPRESSION; GENE EXPRESSION REGULATION; HEAT; LIPID RAFT; MICROBIAL ATTENUATION; NONHUMAN; PROTEIN EXPRESSION; STAPHYLOCOCCUS AUREUS;

ANIMALS; ANTIGENS, BACTERIAL; CATTLE; CELL LINE; EPITHELIAL CELLS; FEMALE; GENE EXPRESSION; HOT TEMPERATURE; IMMUNITY, INNATE; INTERLEUKIN-1BETA; JNK MITOGEN-ACTIVATED PROTEIN KINASES; LIPOPEPTIDES; MAMMARY GLANDS, ANIMAL; MEMBRANE MICRODOMAINS; MITOGEN-ACTIVATED PROTEIN KINASES; NF-KAPPA B; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PROTEIN KINASE INHIBITORS; RNA, MESSENGER; SIGNAL TRANSDUCTION; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCUS AUREUS; TRANSCRIPTION FACTOR AP-1; TRANSCRIPTION FACTOR RELA; VACCINATION; VACCINES, ATTENUATED;

BOVINAE; STAPHYLOCOCCUS AUREUS;

EID: 79960087852     PISSN: 01479571     EISSN: 18781667     Source Type: Journal    
DOI: 10.1016/j.cimid.2011.04.004     Document Type: Article

References (43)

1. Zhao X., Lacasse P. Mammary tissue damage during bovine mastitis: causes and control. J Anim Sci 2008, 86:57-65.
2. Shim E.H., Shanks R.D., Morin D.E. Milk loss and treatment costs associated with two treatment protocols for clinical mastitis in dairy cows. J Dairy Sci 2004, 87:2702-2708.
3. Yang W., Zerbe H., Petzl W., Brunner R.M., Gunther J., Draing C., et al. Bovine TLR2 and TLR4 properly transduce signals from Staphylococcus aureus and E. coli, but S. aureus fails to both activate NF-kappaB in mammary epithelial cells and to quickly induce TNF-alpha and interleukin-8 (CXCL8) expression in the udder. Mol Immunol 2008, 45:1385-1397.
4. Smith K.L., Hogan J.S. Environmental mastitis. Vet Clin North Am Food Anim Pract 1993, 9:489-498.
5. Barkema H.W., Schukken Y.H., Zadoks R.N. The role of cow, pathogen, and treatment regimen in the therapeutic success of bovine Staphylococcus aureus mastitis. J Dairy Sci 2006, 89:1877-1895. [invited review].
6. Chaffer M., Leitner G., Winkler M., Glickman A., Krifucks O., Ezra E., et al. Coagulase-negative staphylococci and mammary gland infections in cows. Zentralbl Veterinarmed B 1999, 46:707-712.
7. Anaya-Lopez J.L., Contreras-Guzman O.E., Carabez-Trejo A., Baizabal-Aguirre V.M., Lopez-Meza J.E., Valdez-Alarcon J.J., et al. Invasive potential of bacterial isolates associated with subclinical bovine mastitis. Res Vet Sci 2006, 81:358-361.
8. Vann J.M., Proctor R.A. Ingestion of Staphylococcus aureus by bovine endothelial cells results in time- and inoculum-dependent damage to endothelial cell monolayers. Infect Immun 1987, 55:2155-2163.
9. Wesson C.A., Deringer J., Liou L.E., Bayles K.W., Bohach G.A., Trumble W.R. Apoptosis induced by Staphylococcus aureus in epithelial cells utilizes a mechanism involving caspases 8 and 3. Infect Immun 2000, 68:2998-3001.
10. Oviedo-Boyso J., Cardoso-Correa B.I., Cajero-Juarez M., Bravo-Patino A., Valdez-Alarcon J.J., Baizabal-Aguirre V.M. The capacity of bovine endothelial cells to eliminate intracellular Staphylococcus aureus and Staphylococcus epidermidis is increased by the proinflammatory cytokines TNF-alpha and IL-1beta. FEMS Immunol Med Microbiol 2008, 54:53-59.
11. Hultgren O.H., Svensson L., Tarkowski A. Critical role of signaling through IL-1 receptor for development of arthritis and sepsis during Staphylococcus aureus infection. J Immunol 2002, 168:5207-5212.
12. Miller L.S., Pietras E.M., Uricchio L.H., Hirano K., Rao S., Lin H., et al. Inflammasome-mediated production of IL-1beta is required for neutrophil recruitment against Staphylococcus aureus in vivo. J Immunol 2007, 179:6933-6942.
13. Verdrengh M., Thomas J.A., Hultgren O.H. IL-1 receptor-associated kinase 1 mediates protection against Staphylococcus aureus infection. Microbes Infect 2004, 6:1268-1272.
14. di Giovine F.S., Duff G.W. Interleukin-1: the first interleukin. Immunol Today 1990, 11:13-20.
15. Dinarello C.A. Interleukin-1beta. Crit Care Med 2005, 33:S460-S462.
16. Tamaru M., Tomura K., Sakamoto S., Tezuka K., Tamatani T., Narumi S. Interleukin-1beta induces tissue- and cell type-specific expression of adhesion molecules in vivo. Arterioscler Thromb Vasc Biol 1998, 18:1292-1303.
17. Dinarello C.A. The IL-1 family and inflammatory diseases. Clin Exp Rheumatol 2002, 20:S1-13.
18. Petrilli V., Martinon F. The inflammasome, autoinflammatory diseases, and gout. Joint Bone Spine 2007, 74:571-576.
19. Dinarello C.A. The interleukin-1 family: 10 years of discovery. FASEB J 1994, 8:1314-1325.
20. Mazzilli M, Zecconi A. Assessment of epithelial cells' immune and inflammatory response to Staphylococcus aureus when exposed to a macrolide. J Dairy Res 2010;77:404-10.
21. Ryu Y.H., Baik J.E., Yang J.S., Kang S.S., Im J., Yun C.H., et al. Differential immunostimulatory effects of Gram-positive bacteria due to their lipoteichoic acids. Int Immunopharmacol 2009, 9:127-133.
22. Venza I., Cucinotta M., Caristi S., Mancuso G., Teti D. Transcriptional regulation of IL-8 by Staphylococcus aureus in human conjunctival cells involves activation of AP-1. Invest Ophthalmol Vis Sci 2007, 48:270-276.
23. Irazoqui J.E., Troemel E.R., Feinbaum R.L., Luhachack L.G., Cezairliyan B.O., Ausubel F.M. Distinct pathogenesis and host responses during infection of C. elegans by P. aeruginosa and S. aureus. PLoS Pathog 2010, 6:e1000982.
24. Li B., Li J., Pan X., Ding G., Cao H., Jiang W., et al. Artesunate protects sepsis model mice challenged with Staphylococcus aureus by decreasing TNF-alpha release via inhibition TLR2 and Nod2 mRNA expressions and transcription factor NF-kappaB activation. Int Immunopharmacol 2010, 10:344-350.
25. Zaas D.W., Duncan M., Rae Wright J., Abraham S.N. The role of lipid rafts in the pathogenesis of bacterial infections. Biochim Biophys Acta 2005, 1746:305-313.
26. Chang L., Karin M. Mammalian MAP kinase signalling cascades. Nature 2001, 410:37-40.
27. Kang J.S., Yoon Y.D., Lee K.H., Park S.K., Kim H.M. Costunolide inhibits interleukin-1beta expression by down-regulation of AP-1 and MAPK activity in LPS-stimulated RAW 264.7 cells. Biochem Biophys Res Commun 2004, 313:171-177.
28. Gray J.G., Chandra G., Clay W.C., Stinnett S.W., Haneline S.A., Lorenz J.J., et al. A CRE/ATF-like site in the upstream regulatory sequence of the human interleukin 1 beta gene is necessary for induction in U937 and THP-1 monocytic cell lines. Mol Cell Biol 1993, 13:6678-6689.
29. Hiscott J., Marois J., Garoufalis J., D'Addario M., Roulston A., Kwan I., et al. Characterization of a functional NF-kappa B site in the human interleukin-1 beta promoter: evidence for a positive autoregulatory loop. Mol Cell Biol 1993, 13:6231-6240.
30. Shirakawa F., Saito K., Bonagura C.A., Galson D.L., Fenton M.J., Webb A.C., et al. The human prointerleukin-1 beta gene requires DNA sequences both proximal and distal to the transcription start site for tissue-specific induction. Mol Cell Biol 1993, 13:1332-1344.
31. Fournier B., Philpott D.J. Recognition of Staphylococcus aureus by the innate immune system. Clin Microbiol Rev 2005, 18:521-540.
32. Barrett J.J., Hogan J.S., Weiss W.P., Smith K.L., Sordillo L.M. Concentrations of alpha-tocopherol after intramammary infusion of Escherichia coli or lipopolysaccharide. J Dairy Sci 1997, 80:2826-2832.
33. Strandberg Y., Gray C., Vuocolo T., Donaldson L., Broadway M., Tellam R. Lipopolysaccharide and lipoteichoic acid induce different innate immune responses in bovine mammary epithelial cells. Cytokine 2005, 31:72-86.
34. Dinarello C.A. Immunological and inflammatory functions of the interleukin-1 family. Annu Rev Immunol 2009, 27:519-550.
35. Martinon F., Tschopp J. Inflammatory caspases: linking an intracellular innate immune system to autoinflammatory diseases. Cell 2004, 117:561-574.
36. Franchi L., Eigenbrod T., Munoz-Planillo R., Nunez G. The inflammasome: a caspase-1-activation platform that regulates immune responses and disease pathogenesis. Nat Immunol 2009, 10:241-247.
37. Takeuchi O., Hoshino K., Kawai T., Sanjo H., Takada H., Ogawa T., et al. Differential roles of TLR2 and TLR4 in recognition of Gram-negative and Gram-positive bacterial cell wall components. Immunity 1999, 11:443-451.
38. Han S.H., Kim J.H., Martin M., Michalek S.M., Nahm M.H. Pneumococcal lipoteichoic acid (LTA) is not as potent as staphylococcal LTA in stimulating Toll-like receptor 2. Infect Immun 2003, 71:5541-5548.
39. Dziarski R., Gupta D. Staphylococcus aureus peptidoglycan is a toll-like receptor 2 activator: a reevaluation. Infect Immun 2005, 73:5212-5216.
40. Hashimoto M., Tawaratsumida K., Kariya H., Aoyama K., Tamura T., Suda Y. Lipoprotein is a predominant Toll-like receptor 2 ligand in Staphylococcus aureus cell wall components. Int Immunol 2006, 18:355-362.
41. Hashimoto M., Tawaratsumida K., Kariya H., Kiyohara A., Suda Y., Krikae F., et al. Not lipoteichoic acid but lipoproteins appear to be the dominant immunobiologically active compounds in Staphylococcus aureus. J Immunol 2006, 177:3162-3169.
42. Schmaler M., Jann N.J., Ferracin F., Landolt L.Z., Biswas L., Gotz F., et al. Lipoproteins in Staphylococcus aureus mediate inflammation by TLR2 and iron-dependent growth in vivo. J Immunol 2009, 182:7110-7118.
43. Bubeck Wardenburg J., Williams W.A., Missiakas D. Host defenses against Staphylococcus aureus infection require recognition of bacterial lipoproteins. Proc Natl Acad Sci U S A 2006, 103:13831-13836.